Authors:
Roth, BL
Ernsberger, P
Steinberg, S
Rao, S
Rauser, L
Savage, J
Hufeisen, S
Berridge, MS
Muzic, RF
Citation: Bl. Roth et al., The in vitro pharmacology of the beta-adrenergic receptor pet ligand (s)-fluorocarazolol reveals high affinity for cloned beta-adrenergic receptors and moderate affinity for the human 5-HT1A receptor, PSYCHOPHAR, 157(1), 2001, pp. 111-114
Authors:
Qiao, LX
Zhao, LY
Rong, SB
Wu, XW
Wang, SM
Fujii, T
Kazanietz, MG
Rauser, L
Savage, J
Roth, BL
Flippen-Anderson, J
Kozikowski, AP
Citation: Lx. Qiao et al., Rational design, synthesis, and biological evaluation of rigid pyrrolidoneanalogues as potential inhibitors of prostate cancer cell growth, BIOORG MED, 11(8), 2001, pp. 955-959
Authors:
Runyon, SP
Savage, JE
Taroua, M
Roth, BL
Glennon, RA
Westkaemper, RB
Citation: Sp. Runyon et al., Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene, BIOORG MED, 11(5), 2001, pp. 655-658
Authors:
Westkaemper, RB
Runyon, SP
Savage, JE
Roth, BL
Glennon, RA
Citation: Rb. Westkaemper et al., Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor, BIOORG MED, 11(4), 2001, pp. 563-566
Authors:
Huang, YY
Kegeles, LS
Bae, SA
Hwang, DR
Roth, BL
Savage, JE
Laruelle, M
Citation: Yy. Huang et al., Synthesis of potent and selective dopamine D-4 antagonists as candidate radioligands, BIOORG MED, 11(11), 2001, pp. 1375-1377
Authors:
Gray, JA
Sheffler, DJ
Bhatnagar, A
Woods, JA
Hufeisen, SJ
Benovic, JL
Roth, BL
Citation: Ja. Gray et al., Cell-type specific effects of endocytosis inhibitors on 5-Hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells, MOLEC PHARM, 60(5), 2001, pp. 1020-1030
Authors:
Rauser, L
Savage, JE
Meltzer, HY
Roth, BL
Citation: L. Rauser et al., Inverse agonist actions of typical and atypical antipsychotic drugs at thehuman 5-hydroxytryptamine(2C) receptor, J PHARM EXP, 299(1), 2001, pp. 83-89
Authors:
Bhatnagar, A
Willins, DL
Gray, JA
Woods, J
Benovic, JL
Roth, BL
Citation: A. Bhatnagar et al., The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis, J BIOL CHEM, 276(11), 2001, pp. 8269-8277
Authors:
Egan, C
Grinde, E
Dupre, A
Roth, BL
Hake, M
Teitler, M
Herrick-Davis, K
Citation: C. Egan et al., Agonist high and low affinity state ratios predict drug intrinsic activityand a revised ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptors, SYNAPSE, 35(2), 2000, pp. 144-150
Authors:
Shapiro, DA
Kristiansen, K
Kroeze, WK
Roth, BL
Citation: Da. Shapiro et al., Differential modes of agonist binding to 5-Hydroxytryptamine(2A) serotoninreceptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5, MOLEC PHARM, 58(5), 2000, pp. 877-886
Authors:
Kristiansen, K
Kroeze, WK
Willins, DL
Gelber, EI
Savage, JE
Glennon, RA
Roth, BL
Citation: K. Kristiansen et al., A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT2A serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism, J PHARM EXP, 293(3), 2000, pp. 735-746
Authors:
Rothman, RB
Baumann, MH
Savage, JE
Rauser, L
McBride, A
Hufeisen, SJ
Roth, BL
Citation: Rb. Rothman et al., Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications, CIRCULATION, 102(23), 2000, pp. 2836-2841
Authors:
Willins, DL
Berry, SA
Alsayegh, L
Backstrom, JR
Sanders-Bush, E
Friedman, L
Roth, BL
Citation: Dl. Willins et al., Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo, NEUROSCIENC, 91(2), 1999, pp. 599-606
Authors:
Gelber, EI
Kroeze, WK
Willins, DL
Gray, JA
Sinar, CA
Hyde, EG
Gurevich, V
Benovic, J
Roth, BL
Citation: Ei. Gelber et al., Structure and function of the third intracellular loop of the 5-hydroxytryptamine(2A) receptor: The third intracellular loop is alpha-helical and binds purified arrestins, J NEUROCHEM, 72(5), 1999, pp. 2206-2214
Authors:
Westkaemper, RB
Runyon, SP
Bondarev, ML
Savage, JE
Roth, BL
Glennon, RA
Citation: Rb. Westkaemper et al., 9-(aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist, EUR J PHARM, 380(1), 1999, pp. R5-R7
Authors:
Rajkowska, G
Miguel-Hidalgo, JJ
Wei, JR
Dilley, G
Pittman, SD
Meltzer, HY
Overholser, JC
Roth, BL
Stockmeier, CA
Citation: G. Rajkowska et al., Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression, BIOL PSYCHI, 45(9), 1999, pp. 1085-1098